VENUSREM — Venus Remedies Share News
0.000.00%
Last trade - 00:00- IN₹16.56bn
- IN₹15.76bn
- IN₹7.70bn
Brief: Venus Remedies Secures Marketing Authorization For Pemetrexed 500 MG In Philippines
India's Venus Remedies rises after co to lauch unit in Hungary
Brief: Venus Remedies Approved Set Up Of Hungary Unit To Expand Eastern Europe Market Presence
India's Venus Remedies hits four-month high on drug supply contract win
India's Venus Remedies rises on UNICEF order
Brief: Venus Remedies March-Quarter Consol Net Profit Falls
Brief: Venus Remedies Awarded 25 Mln Rupees PLI Scheme
Brief: Venus Remedies Gets Good Manufacturing Practices Approval From UNICEF
Brief: Venus Remedies Receives Marketing Authorizations For Oncology Drugs In Ukraine
Brief: Venus Remedies Got Its First Disbursement Of 75 Million Rupees Under PLI Scheme
Brief: Venus Remedies Dec-Quarter Consol Net Profit Rises
Brief: Venus Remedies Attains Gmp Certification From Libya
India's Venus Remedies gains on marketing nod for two drugs in Europe
Brief: Venus Remedies Secures New Marketing Authorizations For Docetaxel And Gemcitabine In Malta, Europe
India's Venus Remedies rises most in 1 month on nod to sell chemo drugs
Brief: Venus Remedies Achieves Marketing Authorizations For Docetaxel In Israel And Cytarabine In Colombia
Brief: Venus Remedies Forays Into Wellness Arena
Brief: Venus Remedies Obtains Three New Marketing Authorizations For Enoxaparin From Bahrain
Brief: Venus Remedies Says Granted Market Authorization For Enoxaparin In Azerbaijan